Biguanide-functionalized peptide mimics effectively combat drug-resistant ESKAPE pathogens and meningitis.

Jiang, Weinan; Zhou, Min; Chen, Kang; Xiao, Ximian; Shi, Jia; Zhang, Haodong; Xie, Jiayang; Chen, Sheng et al. · Nat Commun · 2025

basic_science · Level V

Where this comes from

Abstract

ESKAPE pathogens-induced meningitis seriously threatens human health due to antimicrobial resistance and low permeability of blood-brain barrier (BBB). It's a promising strategy to combat drug-resistant pathogens using synthetic mimics of host defense peptide (HDP) bearing positive charges that are mainly provided by amine or guanidine. Here, we report that biguanide serves as a type of positively charged moiety to design HDP mimics. Biguanide exerts a stronger interaction with bacterial membrane phospholipids via bidentate hydrogen bonds than do amine and guanidine. The biguanide-functionalized HDP mimic, PBGProOx<sub>20</sub>, targets bacterial membrane phospholipids to show potent activity against all ESKAPE pathogens and does not induce antimicrobial resistance. PBGProOx<sub>20</sub> exhibits promising BBB-penetrating property and displays potent therapeutic effects in female mice full-thickness infection model, sub-cutaneous infection model, kidney infection model, peritonitis model, and meningitis model. This study provides a promising strategy for designing HDP mimics to combat ESKAPE pathogens and meningitis.

Medical subject headings